The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant ...

Pfizer has ended development of a B7-H4-directed antibody-drug conjugate (ADC), triggering a $1 billion impairment charge. | ...

C&EN’s tabulation follows approvals from the FDA’s Center for Drug Evaluation and Research; therefore, it does not include blood products, gene therapies, vaccines, and other therapies that ...

Learn about the consultation and how to provide your feedback. The consultation closes on March 8, 2025. Drugs included on the list for exceptional importation and sale are called "designated drugs".

Sjögren’s antibody testing is done using a blood sample. It checks antibody levels, including anti-SS-A (also called anti-Ro) and anti-SS-B (also called anti-La). Anti-SS-A and anti-SS-B are ...

Avacta is stepping up development of its peptide-drug conjugate (PDC), kicking off expansion cohorts in multiple tumor types after seeing one partial response in 10 salivary gland cancer patients.

A “Jekyll-and-Hyde character” who was considered a role model in his community was sentenced ... during the shootout sparked by a beef over drug turf. Hassen, clad in a bow tie, dark suit ...

"The $7.3 billion is the difference between what they are reimbursing themselves and what it is estimated to cost them to acquire the drug," an FTC ... their pricing model. "We're confident ...

stressing antibody-drug conjugates (ADCs) and multi-specific antibody therapeutics as the two new growth driver that will boost its expansion from a biosimilar-focused company. ADCs are viewed as ...

Bucharest mayor Nicușor Dan announced that his administration will draw inspiration from the Icelandic model to combat and prevent drug use among young people. The mayor also stated that ...

Drugmakers raised the list prices on 575 name-brand drugs in just the first two days of the new year, according to drug price research firm 46brooklyn. Drugs for diabetes, HIV, cancer saw price ...